CCCRCG Research Award

The Canadian Critical Care Trials Group (CCCTG) and the Canadian Critical Care Research Coordinators Group (CCCRCG) extend congratulations to Chantale Pineau and Nicole Marten, recipients of the CCCRCG Research Award.

Their study, “Innovative consent design: A sub-study of the ATTACC-CAP clinical trial,” will help inform the efficacy of alternative methods of consenting outside the typical informed consent form that is used across most CCCTG trials. The objectives of the study are 1) to determine the most appropriate novel consent methods to be studied, and 2) to pilot the study of novel consent methodology at a single centre to assess the feasibility of scaling to a multicentre prospective study.

Clinical trials are becoming more complex with the growing rate of adaptive and multi-platform trials, which further increases the need to find an alternative method of consenting to improve participant comprehension of the information being presented. The study team hopes the protocol can be easily adapted for other CCCTG trials in order to have a pooled analysis with a more extensive patient population, including those in different illness severity groups and age groups.

Innovative consent design: A sub-study of the ATTACC-CAP clinical trial

Investigators:

Chantale Pineau
Nicole Marten
Dayna Solvason
Dr. Sylvain Lother
Dr. Ryan Zarychanski